drugset / Trial / NCT01224353

Efficacy and Safety Study of Thioctacid Oral Tablets 600mg to Treat Chinese Diabetic Patients With Distal Symmetric Polyneuropathy

NCT01224353

Phase 2/3 Unknown 200 enrolled NovaMed Pharmaceuticals Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of the study is to evaluate the efficacy on overall neuropathic sensory symptom improvement of Thioctacid tablet 600mg once daily vs. placebo in 6-weeks' treatment in Chinese diabetic patients with distal symmetric polyneuropathy (DSP).

Timeline

Start
2010-11
Primary completion
2011-05
Completion
2011-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator alpha-lipoic acid Small molecule 600 mg Oral

Indications

No indication recorded.